{"id":1660,"date":"2026-05-31T07:51:38","date_gmt":"2026-05-31T07:51:38","guid":{"rendered":"https:\/\/one-peptides.com\/mk-677-vs-hgh-fragment-176-191-comparison-of-two-approaches-to-the-growth-hormone-axis\/"},"modified":"2026-10-03T11:30:52","modified_gmt":"2026-10-03T11:30:52","slug":"mk-677-vs-hgh-fragment-176-191-comparison-of-two-approaches-to-the-growth-hormone-axis","status":"publish","type":"post","link":"https:\/\/one-peptides.com\/es\/mk-677-vs-hgh-fragment-176-191-comparison-of-two-approaches-to-the-growth-hormone-axis\/","title":{"rendered":"MK-677 vs HGH Fragment 176-191 – Comparison of Two Approaches to the Growth Hormone Axis"},"content":{"rendered":"
\n\tHome<\/a>\n<\/span>\u00bb<\/span>\n\tSARMs & modulators<\/a>\n<\/span>\u00bb<\/span>\n\tMK-677 vs HGH Fragment 176-191 \u2013 Comparison of Two Approaches to the Growth Hormone Axis\n<\/span><\/div><\/div>\n

Two molecules. Two fundamentally different approaches to the same hormonal axis. MK-677 tells the pituitary gland to \u201cproduce more growth hormone.\u201d HGH Fragment 176-191 tells fat tissue to “act as if you were getting growth hormone – without the rest of its effects.” One stimulates the endogenous production of the entire hormone. The second provides an isolated fragment responsible for one specific action. Which of these mechanisms suits your research goals? It depends on the question you are looking for an answer to.<\/p>\n

\n

\ud83d\udcd6 The following article is educational and is a review of published scientific literature. The studies described were performed in animal models or in vitro, unless otherwise noted. This does not constitute medical advice.<\/p>\n<\/blockquote>\n

MK-677 – stimulation of endogenous growth hormone<\/h2>\n

MK-677 (Ibutamoren) is an oral ghrelin mimetic that binds to the GHS-R1a receptor in the pituitary gland and stimulates pulsatile release of growth hormone (GH). Cascade effect: increase in GH \u2192 increase in IGF-1 in the liver \u2192 anabolic effect in muscles, bones and other tissues.<\/p>\n

Key Feature: MK-677 does not provide external hormone. It activates its own GH production mechanism – maintaining the physiological pulsatile rhythm. Clinical studies in humans (Nass et al., 2008) confirmed an increase in GH and IGF-1 to values observed in young adults, an increase in lean body mass and an improvement in sleep architecture.<\/p>\n

It’s a top-down approach – stimulate the pituitary gland and the rest of the GH\/IGF-1 axis will respond physiologically. The effects are wide-ranging: not only lipolysis, but also muscle anabolism, improved bone mineralization, improved sleep and regeneration.<\/p>\n

A detailed discussion of the mechanism, research and safety profile of MK-677 can be found in a separate article MK-677 (Ibutamoren) – action, research and research use<\/a>.<\/p>\n

HGH Fragment 176-191 – isolated fragment of growth hormone<\/h2>\n

HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176-191 of human growth hormone – C-terminal fragment, which in preclinical studies has shown lipolytic properties (supporting the breakdown of fat tissue).<\/p>\n

The concept is elegant: full-size growth hormone (191 amino acids) produces many effects – anabolic, lipolytic, diabetogenic (insulin resistance), growth of internal organs. Fragment 176-191 is an attempt to isolate one of these effects: lipolysis, without the rest of the “package”.<\/p>\n

Preclinical studies in a mouse model have shown that Fragment 176-191:<\/p>\n